Recurrent Clostridioides Difficile Infection
Recurrent Clostridioides difficile infection (CDI) presents a growing healthcare challenge worldwide. It is characterized by the reappearance of symptomatic infection within eight weeks following the completion of appropriate antibiotic therapy. Recurrent CDI significantly increases morbidity, healthcare costs, and the risk of further recurrences, necessitating a comprehensive and sustained management approach. Causes and Risk Factors for